Brief: Cassava Sciences Reports Q2 2023 Financial Results And Operating Updates

Filana Therapeutics

03/08/2023 14:08

Cassava Sciences Inc  SAVA.O :
    * CASSAVA SCIENCES REPORTS Q2 2023 FINANCIAL RESULTS AND
OPERATING
UPDATES
    * CASSAVA SCIENCES INC Q2 LOSS PER SHARE $0.63
    * CASSAVA SCIENCES INC - NET CASH USE IN SECOND HALF 2023 IS
EXPECTED TO BE $40 TO $50 MILLION

Source text for Eikon:  ID:nGNX1n2HPj 
Further company coverage:  SAVA.O